499 related articles for article (PubMed ID: 28577718)
1. Intrahepatic cholangiocarcinoma: Molecular markers for diagnosis and prognosis.
Rahnemai-Azar AA; Weisbrod A; Dillhoff M; Schmidt C; Pawlik TM
Surg Oncol; 2017 Jun; 26(2):125-137. PubMed ID: 28577718
[TBL] [Abstract][Full Text] [Related]
2. Intrahepatic cholangiocarcinoma: current management and emerging therapies.
Rahnemai-Azar AA; Weisbrod AB; Dillhoff M; Schmidt C; Pawlik TM
Expert Rev Gastroenterol Hepatol; 2017 May; 11(5):439-449. PubMed ID: 28317403
[TBL] [Abstract][Full Text] [Related]
3. Molecular diagnosis of intrahepatic cholangiocarcinoma.
Haga H; Patel T
J Hepatobiliary Pancreat Sci; 2015 Feb; 22(2):114-23. PubMed ID: 25267595
[TBL] [Abstract][Full Text] [Related]
4. Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances.
Sirica AE; Gores GJ; Groopman JD; Selaru FM; Strazzabosco M; Wei Wang X; Zhu AX
Hepatology; 2019 Apr; 69(4):1803-1815. PubMed ID: 30251463
[TBL] [Abstract][Full Text] [Related]
5. Advanced Intrahepatic Cholangiocarcinoma: Post Hoc Analysis of the ABC-01, -02, and -03 Clinical Trials.
Lamarca A; Ross P; Wasan HS; Hubner RA; McNamara MG; Lopes A; Manoharan P; Palmer D; Bridgewater J; Valle JW
J Natl Cancer Inst; 2020 Feb; 112(2):200-210. PubMed ID: 31077311
[TBL] [Abstract][Full Text] [Related]
6. Advances in the Diagnosis and Treatment of Patients with Intrahepatic Cholangiocarcinoma.
Ejaz A; Cloyd JM; Pawlik TM
Ann Surg Oncol; 2020 Feb; 27(2):552-560. PubMed ID: 31555936
[TBL] [Abstract][Full Text] [Related]
7. Current approaches to the diagnosis and treatment of cholangiocarcinoma.
Reddy SB; Patel T
Curr Gastroenterol Rep; 2006 Feb; 8(1):30-7. PubMed ID: 16510032
[TBL] [Abstract][Full Text] [Related]
8. Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma.
Esnaola NF; Meyer JE; Karachristos A; Maranki JL; Camp ER; Denlinger CS
Cancer; 2016 May; 122(9):1349-69. PubMed ID: 26799932
[TBL] [Abstract][Full Text] [Related]
9. Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis.
Banales JM; Iñarrairaegui M; Arbelaiz A; Milkiewicz P; Muntané J; Muñoz-Bellvis L; La Casta A; Gonzalez LM; Arretxe E; Alonso C; Martínez-Arranz I; Lapitz A; Santos-Laso A; Avila MA; Martínez-Chantar ML; Bujanda L; Marin JJG; Sangro B; Macias RIR
Hepatology; 2019 Aug; 70(2):547-562. PubMed ID: 30325540
[TBL] [Abstract][Full Text] [Related]
10. Liver resection and transplantation for intrahepatic cholangiocarcinoma.
Mazzaferro V; Gorgen A; Roayaie S; Droz Dit Busset M; Sapisochin G
J Hepatol; 2020 Feb; 72(2):364-377. PubMed ID: 31954498
[TBL] [Abstract][Full Text] [Related]
11. EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma.
;
J Hepatol; 2023 Jul; 79(1):181-208. PubMed ID: 37084797
[TBL] [Abstract][Full Text] [Related]
12. Molecular profiling of intrahepatic cholangiocarcinoma: the search for new therapeutic targets.
Oliveira DV; Zhang S; Chen X; Calvisi DF; Andersen JB
Expert Rev Gastroenterol Hepatol; 2017 Apr; 11(4):349-356. PubMed ID: 28162004
[TBL] [Abstract][Full Text] [Related]
13. Cholangiocarcinoma.
Blechacz BR; Gores GJ
Clin Liver Dis; 2008 Feb; 12(1):131-50, ix. PubMed ID: 18242501
[TBL] [Abstract][Full Text] [Related]
14. Intrahepatic cholangiocarcinoma biomarkers: Towards early detection and personalized pharmacological treatments.
Capuozzo M; Santorsola M; Ferrara F; Cinque C; Farace S; Patrone R; Granata V; Zovi A; Nasti G; Ottaiano A
Mol Cell Probes; 2024 Feb; 73():101951. PubMed ID: 38244704
[TBL] [Abstract][Full Text] [Related]
15. Carbohydrate Antigen 50: Values for Diagnosis and Prognostic Prediction of Intrahepatic Cholangiocarcinoma.
Luang S; Teeravirote K; Saentaweesuk W; Ma-In P; Silsirivanit A
Medicina (Kaunas); 2020 Nov; 56(11):. PubMed ID: 33207685
[No Abstract] [Full Text] [Related]
16. Defining the biology of intrahepatic cholangiocarcinoma: molecular pathways and early detection of precursor lesions.
Gibiino G; Fabbri C; Fagiuoli S; Ianiro G; Fornelli A; Cennamo V
Eur Rev Med Pharmacol Sci; 2017 Feb; 21(4):730-741. PubMed ID: 28272710
[TBL] [Abstract][Full Text] [Related]
17. Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry.
Izquierdo-Sanchez L; Lamarca A; La Casta A; Buettner S; Utpatel K; Klümpen HJ; Adeva J; Vogel A; Lleo A; Fabris L; Ponz-Sarvise M; Brustia R; Cardinale V; Braconi C; Vidili G; Jamieson NB; Macias RI; Jonas JP; Marzioni M; Hołówko W; Folseraas T; Kupčinskas J; Sparchez Z; Krawczyk M; Krupa Ł; Scripcariu V; Grazi GL; Landa-Magdalena A; Ijzermans JN; Evert K; Erdmann JI; López-López F; Saborowski A; Scheiter A; Santos-Laso A; Carpino G; Andersen JB; Marin JJ; Alvaro D; Bujanda L; Forner A; Valle JW; Koerkamp BG; Banales JM
J Hepatol; 2022 May; 76(5):1109-1121. PubMed ID: 35167909
[TBL] [Abstract][Full Text] [Related]
18. Update on the Diagnosis and Treatment of Cholangiocarcinoma.
Doherty B; Nambudiri VE; Palmer WC
Curr Gastroenterol Rep; 2017 Jan; 19(1):2. PubMed ID: 28110453
[TBL] [Abstract][Full Text] [Related]
19. Cholangiocarcinoma.
Patel T
Nat Clin Pract Gastroenterol Hepatol; 2006 Jan; 3(1):33-42. PubMed ID: 16397610
[TBL] [Abstract][Full Text] [Related]
20. A review of the clinical diagnosis and therapy of cholangiocarcinoma.
Yao D; Kunam VK; Li X
J Int Med Res; 2014 Feb; 42(1):3-16. PubMed ID: 24366497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
